Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan;17(1):6-8.
doi: 10.1007/BF03086207.

Cardiac resynchronisation therapy: results from daily practice in Rijnstate Hospital, Arnhem

A M Rolink  1 , F W A Verheugt, H A Bosker
Affiliations

Cardiac resynchronisation therapy: results from daily practice in Rijnstate Hospital, Arnhem

A M Rolink et al. Neth Heart J. 2009 Jan.

Abstract

Background: Cardiac resynchronisation therapy (CRT) is an effective treatment to improve the clinical outcome of selected patients with heart failure. Clinical trials have studied clinical outcome and reported clinical improvements, but clinical consequences and results in daily practice are less well known. We evaluated clinical outcome in all patients with CRT implantation in our centre.

Methods: Data of 119 consecutive patients who met the criteria for CRT implantation in Rijnstate Hospital, Arnhem in the period 28 November 2000 until 1 January 2006 were collected. We analysed implantation procedure, hospitalisation for heart failure or other causes, mortality and device-related events.

Results: In total 119 patients (83 men, 36 women; mean age 69 years) were eligible for CRT. Before implantation they had received optimal pharmacological therapy. Implantation was successful in 97% of patients. Procedural-related complications were seen in eight patients. During follow-up, 22 patients (18.5%: 14 men, 8 women) died. Causes of death were heart failure (11 patients), sudden cardiac death (4 patients) and noncardiac death (7 patients). Hospitalisation occurred 81 times, of which 77 for cardiac reasons. In follow-up the estimated five-year cumulative survival was 70%.

Conclusion: This retrospective study from a single centre showed a high procedural success rate, low prevalence of complications and low mortality in comparison to other studies. Despite better functional capacity, the hospitalisation rate due to heart failure was high. (Neth Heart J 2009;17:6-8.).

Keywords: Arnhem; cardiac resynchronisation therapy; results.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan Meyercurve for survival in the Arnhem population (119 patients).
See this image and copyright information in PMC

References

    1. Bradley DJ, Bradley EA, Baughmann KL, Berger RD, Calkins H, Goodman SN, et al. Cardiac resynchronization and death from progressive heart failure: A Meta-analysis of Randomized Controlled Trials. JAMA 2003;289:730-40. - PubMed
    1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53. - PubMed
    1. Valls-Bertault V, Mansourati J, Gilard M, Etienne Y, Munier S, Blanc J-J. Adverse events with transvenous left ventricular pacing in patients with severe heart failure: early experience from a single centre. Europace 2001;3:60-3. - PubMed
    1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kas DA, De Marco T, et al., for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50. - PubMed
    1. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al., for the Cardiac Resynchronization – Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49. - PubMed

LinkOut - more resources